Abstract
The methylation state of 5′-CG-3′ sites is known to be linked to the regulation of promoter function by modulating DNA-protein interactions and to the structure of chromatin. As part of a project to determine methylation patterns in the human genome, we examined the methylation profiles of several genes for human erythroid membrane proteins: ELB42 (protein 4.2), EPB3 (band 3), SPTB gene (β-spectrin), and ANK1 (ankyrin). The bisulfite protocol of the genomic sequencing method was applied. The number of 5′-CG-3′ dinucleotides was the most abundant in SPTB and ANK1, much less in EPB3, and the least in ELB42. In the DNA of peripheral blood mononuclear cells from healthy individuals, the promoter regions of EPB3 and ELB42 were extensively methylated, but the SPTB and ANK1 promoters were totally unmethylated. We also investigated methylation profiles in peripheral blood mononuclear cells from patients with red cell membrane diseases, such as complete protein 4.2 deficiency due to ELB42 mutations, hereditary spherocytosis with EPB3 mutations, and hereditary elliptocytosis with SPTB mutations. The DNA methylation states in these genes of erythroid cells, which we obtained at the second phase of the 2-phase liquid culture of erythroid precursor cells in the peripheral blood, were essentially identical or very similar to those of peripheral blood mononuclear cells. In disease states, the DNA methylation profiles of these red cell membrane protein genes were essentially not different from those in healthy individuals (statistically not significant).
Similar content being viewed by others
References
Yawata Y. Cell Membrane: The Red Blood Cell as a Model. Weinheim, Germany: Wiley-VCH; 2003.
Eber SE, Lux SE. Hereditary spherocytosis: defects in proteins that connect the membrane skeleton to the lipid bilayer. Semin Hematol. 2004;41:118–141.
Gallagher PG. Hereditary elliptocytosis: spectrin and protein 4.1R. Semin Hematol. 2004;41:142–164.
Tanner MJ. Molecular and cellular biology of the erythrocyte anion exchanger (AE1). Semin Hematol. 1993;30:34–57.
Winkelmann JC, Chang JG, Tse WT, Scarpa AL, Marchesi VI, Forget BG. Full-length sequence of the cDNA from human erythroid β-spectrin. J Biol Chem. 1990;265:11827–11832.
Cohen CM, Dotimas E, Korsgren C. Human erythrocyte membrane protein band 4.2 (pallidin). Semin Hematol. 1993;30:119–137.
Yawata Y. Red cell membrane protein band 4.2: phenotypic, genetic and electron microscopic aspects. Biochim Biophys Acta. 1994;1204:131–148.
Yawata A, Kanzaki A, Gilsanz F, Delaunay J, Yawata Y. A markedly disrupted skeletal network with abnormally distributed intramembrane particles in complete protein 4.1-deficient red blood cells (allele 4.1 Madrid): implications regarding a critical role of protein 4.1 in maintenance of the integrity of the blood cell membrane. Blood. 1997;90:2471–2481.
Boffa LC, Walker J, Chen TA, Sterner R, Mariani MR, Allfrey VG. Factors affecting nucleosome structure in transcriptionally active chromatin: histone acetylation, nascent RNA, and inhibitors of RNA synthesis. Eur J Biochem. 1990;194:811–823.
Doerfler W. DNA methylation and gene activity. Annu Rev Biochem. 1983;52:93–124.
Munnes M, Schetter C, Hölker I, Doerfler W. A fully 5′-CG-3′ but not a 5′-CCGG-3′ methylated late frog virus 3 promoter retains activity. J Virol. 1995;69:2240–2247.
Doerfler W. Foreign DNA in Mammalian Systems. Weinheim, Germany: Wiley-VCH; 2000.
Frommer M, McDonald LE, Millar DS, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A. 1992;89:1827–1831.
Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 1994;22:2990–2997.
Kochanek S, Toth M, Dehmel A, Renz D, Doerfler W. Interindi- vidual concordance of methylation profiles in human genes for tumor necrosis factors α and β. Proc Natl Acad Sci U S A. 1990;87:8830–88344.
Kochanek S, Radbruch A, Tesch H, Renz D, Doerfler W. DNA methylation profiles in the human genes for tumor necrosis factors α and β in subpopulations of leukocytes and in leukemias. Proc Natl Acad Sci U S A. 1991;88:5759–5763.
Wada H, Suda T, Miura Y, Kajii E, Ikemoto S, Yawata Y. Expression of major blood group antigens on human erythroid cells in a two phase liquid culture system. Blood. 1990;75:505–511.
Wada H, Kanzaki A, Yawata A, et al. Late expression of red cell membrane protein 4.2 in normal human erythroid maturation with seven isoforms of the protein 4.2 gene. Exp Hematol. 1999;27:54–62.
Zeschnigk M, Schmitz B, Dittrich B, Buiting K, Horsthemke B, Doerfler W. Imprinted segments in the human genome: different DNA methylation patterns in the Prader-Willi/Angelman syndrome region as determined by the genomic sequencing method. Hum Mol Genet. 1997;6:387–395.
Remus R, Kämmer C, Heller H, Schmitz B, Schell G, Doerfler W. Insertion of foreign DNA into an established mammalian genome can alter the methylation of cellular DNA sequences. J Virol. 1999; 73:1010–1022.
Hanahan D. Studies on transformation of Escherichia coli with plasmids. J Mol Biol. 1983;166:557–580.
Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA. 1997;74:5463–5467.
Munnes M, Zuther I, Schmitz B, Doerfler W. A novel insertional mutation and differentially spliced mRNAs in the human BRCA1 gene. Gene Funct Dis. 2000;1:38–47.
Sadahira Y, Kanzaki A, Wada H, Yawata Y. Immunohistochemical identification of erythroid precursors in paraffin embedded bone marrow sections: spectrin is a superior marker to glycophorin. J Clin Pathol. 1999;52:919–921.
Bouhassira EE, Schwartz RS, Yawata Y, et al. An alanine-to-threonine substitution in protein 4.2 cDNA is associated with Japanese form of hereditary hemolytic anemia (protein 4.2NIPPON). Blood. 1992;79:1846–1854.
Inoue T, Kanzaki A, Yawata A, et al. Electron microscopic and physicobiochemical studies on disorganization of the cytoskeletal network and integral protein (band 3) in red cells of band 4.2 deficiency with a mutation (codon 142: GCT→ ACT). Int J Hematol. 1994;59:157–175.
Kanzaki A, Yawata Y, Yawata A, et al. Band 4.2 Komatsu: 523 GAT→TAT (175 Asp→ Tyr) in exon 4 of the band 4.2 gene associated with total deficiency of band 4.2, hemolytic anemia with oval- ostomatocytosis and marked disruption of the cytoskeletal network. IntJ Hematol. 1995;61:165–178.
Kanzaki A, Yasunaga M, Okamoto N, et al. Band 4.2 Shiga: 317 CGC→TGC in compound heterozygotes with 142 GCT→ACT result in band 4.2 deficiency and microspherocytosis. Br J Haematol. 1995;91:333–340.
Yawata Y. Band 4.2 abnormalities in human red cells. Am J Med Sci. 1994;307:190–203.
Yawata Y, Yawata A, Kanzaki A, et al. Electron microscopic evidence of impaired intramembrane particles and instability of the cytoskeletal network in band 4.2 deficiency in human red cells. Cell Motil Cytoskeleton. 1996;33:95–105.
Yawata Y, Kanzaki A, Yawata A, Doerfler W, Ozcan R, Eber SW. Characteristic features of genotype and phenotype of hereditary spherocytosis in the Japanese population. Int J Hematol. 2000;71:118–135.
Inoue T, Kanzaki A, Kaku M, et al. Homozygous missense mutation (band 3 Fukuoka: G130R): a mild form of hereditary spherocytosis with near-normal band 3 content and minimal changes of membrane ultrastructure despite moderate protein 4.2 deficiency. Br J Haematol. 1998;102:932–939.
Maillet P, Inoue T, Kanzaki A, et al. Stop codon in exon 30 (E2069X) of β-spectrin gene associated with hereditary elliptocytosis in spectrin Nagoya. Hum Mutat. 1996;8:366–368.
Kruczek I, Doerfler W. Expression of the chloramphenicol acetyl- transferase gene in mammalian cells under the control of aden- ovirus type 12 promoters: effect of promoter methylation on gene expression. Proc Natl Acad Sci U S A. 1983;80:7586–7590.
Langner K-D, Vardimon L, Renz D, Doerfler W. DNA methylation of three 5′ C-C-G-G 3′ sites in the promoter and 5′ region inactivates the E2a gene of adenovirus type 2. Proc NatlAcad Sci U S A.1984;81:2950–2954.
Langner K-D, Weyer U, Doerfler W. Trans effect of the E1 region of adenoviruses on the expression of a prokaryotic gene in mammalian cells: resistance to 5′-CCGG-3′ methylation. Proc Natl Acad Sci U S A.1986;83:1598–1602.
Weisshaar B, Langner K-D, Jüttermann R, et al. Reactivation of the methylation-inactivated late E2A promoter of adenovirus type 2 by E1 A (13S) functions. J Mol Biol. 1988;202:255–270.
Muiznieks I, Doerfler W.The impact of 5′-CG-3′ methylation on the activity of different eukaryotic promoters: a comparative study. FEBS Lett. 1994;344:251–254.
Vardimon L, Kressmann A, Cedar H, Maechler M, Doerfler W. Expression of a cloned adenovirus gene is inhibited by in vitro methylation. Proc Natl Acad Sci USA.1982;79:1073–1077.
Hanspal M, Palek J. Biogenesis of normal and abnormal red blood cell membrane skeleton. Semin Hematol. 1992;29:305–319.
Liu SC, Derick LH. Molecular anatomy of the red blood cell membrane skeleton: structure-function relationship. Semin Hematol. 1992;29:231–243.
Yawata Y, Kanzaki A, Yawata A. Genotypic and phenotypic expressions of protein 4.2 in human erythroid cells. Gene Funct Dis.20001:61–81.
Peters LL, Jindel HK, Gwynn B, et al. Mild spherocytosis and altered red cell ion transport in protein 4.2-null mice. J Clin Invest. 1999;103:1527–1537.
Singal R, Ginder GD. DNA methylation. Blood.1999;93:4059–4070.
Antequera F, Bird A. Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci U S A. 1993;90:11995–11999.
Bird AP.Gene number, noise reduction and biological complexity. Trends Genet. 1995;11:94–100.
Cross SH, Bird AP. CpG islands and genes. Curr Opin Genet Dev. 1995;5:309–314.
Razin A, Cedar H. DNA methylation and gene expression. Micro-biol Rev. 1991;55:451–458.
Bird A. The essentials of DNA methylation. Cell.1992;70:5–8.
Inaba M, Yawata A, Koshino I, et al. Defective anion transport and marked spherocytosis with membrane instability caused by hereditary total deficiency of red cell band 3 in cattle due to a nonsense mutation. J Clin Invest.1996;97:1804–1817.
Rybicki AC, Heath R, Wolf JL, Lubin B, Schwartz RS. Deficiency of protein 4.2 in erythrocytes from a patient with a Coombs negative hemolytic anemia: evidence for a role of protein 4.2 in stabilizing ankyrin on the membrane. J Clin Invest.1988;81:893–901.
Jarolim P, Murray JL, Rubin HL, et al. Characterization of 13 novel band 3 gene defects in hereditary spherocytosis with band 3 deficiency. Blood.1996;88:4366–4374.
Dhermy D, Galand C, Bournier O, et al. Heterogeneous band 3 deficiency in hereditary spherocytosis related to different band 3 gene defects. Br J Haematol. 1997;98:32–40.
Nakanishi H, Kanzaki A, Yawata Y, Yawata A. Ankyrin mutations in hereditary spherocytosis in Japan. Int J Hematol. 2001; 73:54–63.
Kanzaki A, Hayette S, Morle L, et al. Total absence of protein 4.2 and partial deficiency of band 3 in hereditary spherocytosis. Br J Haematol. 1997;99:522–530.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Remus, R., Kanzaki, A., Yawata, A. et al. DNA Methylation in Promoter Regions of Red Cell Membrane Protein Genes in Healthy Individuals and Patients with Hereditary Membrane Disorders. Int J Hematol 81, 385–395 (2005). https://doi.org/10.1532/IJH97.04171
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1532/IJH97.04171